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The mechanisms responsible for resistance to damage in normal cells might deter-
mine chemoresistance in both tumor cells and cancer stem cells (CSC). Relapse due 
to chemoresistant residual disease is a major cause of death in GBM. Increasing body 
of evidence indicates that not only tumor area (TT), but also tissue surrounding the 
tumor border (pTT) of GBM contains tumor cells and CSC, which could contribute 
to the disease progression. Therefore, the need to have a deeper insight in this area 
through identification of the characteristics that confer chemoresistance.
In this study, the expression of molecules involved in chemoresistance was inves-
tigated in samples derived from TT and from pTT at <1 cm from the tumor border, in 
40 patients with GBM. The expression of O6-methylguanine-DNA methyltransferase 
(MGMT), a suicidal DNA repair protein; Breast Cancer Resistance Protein (BCRP1), 
a drug efflux transporter, and A2B5 (c-series gangliosides) has been determined by 
immunohistochemistry. 
The percentage of MGMT positive cells was higher (p<0.0001, paired Student’s t 
test) in pTT (median: 53.5, range: 0.6-92.4) with respect to TT (median: 3.3, range: 0.0-
70.7). The same trend was observed in BCRP1 expression (p<0.02; pTT, median: 27.6, 
range: 1.0-95.6; TT, median: 10.1, range: 0.2-72.1). No difference was found between 
pTT and TT in A2B5 expression (p=0.69, pTT, median: 29.8, range: 0.0-98.4; TT, medi-
an: 26.0, range: 0.0-96.8). Patients were then divided into two groups according to 
presence (group A) or absence (group B) of tumor cells in pTT. The trend previous 
observed in MGMT expression was maintained in both groups, while only in group 
A a statistically significant difference in BCRP1 expression was observed. 
Our results confirm that the tissue surrounding GBM is not a normal tissue, and 
that it represents a frontline of tumor invasion, particularly for the presence of some 
molecules involved in chemoresistance, which could explain the disease recurrence 
after the conventional treatment of GBM. 
Experiments about the expression of above mentioned molecules in CSC from 
pTT and TT are in progress.
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